Showing 10,381 - 10,400 results of 74,781 for search '(( 5 ((we decrease) OR (mean decrease)) ) OR ( 50 ((nn decrease) OR (a decrease)) ))', query time: 1.39s Refine Results
  1. 10381
  2. 10382

    Social interaction of <i>Cdkl5</i> -/Y mice is uniquely altered. by Kosuke Okuda (5150393)

    Published 2018
    “…<p>(A-E) The social interaction test in a novel environment (one-chamber test). <i>Cdkl5</i> -/Y mice show a significant increase in the total duration of contacts (A), a significant increase in the mean duration per contact (B), a significant decrease in the number of contacts (C), a significant decrease in the total duration of active contacts (D), and a significant decrease in the distance traveled (E). …”
  3. 10383
  4. 10384
  5. 10385
  6. 10386

    Model food web mean path length and dominant eigenvalue as a function of nominal size and connectance. by Jane Shevtsov (803549)

    Published 2015
    “…In (a) and (c), mean path length generally decreases with connectance, while the dominant eigenvalue shows a curvilinear pattern. …”
  7. 10387
  8. 10388

    Sema3a inhibits the differentiation of Raw264.7 cells to osteoclasts under 2Gy radiation by reducing inflammation by Bo Huang (30906)

    Published 2018
    “…Raw264.7 cells were divided into four groups: A, receiving no radiation; B, receiving no radiation + 50ngng/ml Sema3a; C, receiving 2Gy radiation; and D, receiving 2Gy radiation +50ngng/ml Sema3a. …”
  9. 10389

    Blocking KDM5B demethylation leads to increased cytokine production and repression of Th2 responses. by Catherine Ptaschinski (756139)

    Published 2015
    “…<p>Following RSV infection, KDM5B is upregulated through unknown mechanisms. KDM5B demethylates H3K4 at the promoter regions of proinflammatory cytokines, leading to decreased transcription. …”
  10. 10390

    Targeting Tyrosinase: Development and Structural Insights of Novel Inhibitors Bearing Arylpiperidine and Arylpiperazine Fragments by Stefania Ferro (76724)

    Published 2018
    “…The crystal structures of TyBm with inhibitor <b>3</b> (IC<sub>50</sub> value of 25.11 μM) and <b>16</b> (IC<sub>50</sub> value of 5.25 μM) were solved, confirming the binding poses hypothesized by in silico studies and revealing the main molecular determinants for the binding recognition of the inhibitors.…”
  11. 10391
  12. 10392
  13. 10393

    Diurnal change of retinal vessel density and mean ocular perfusion pressure in patients with open-angle glaucoma by Sung Uk Baek (6640382)

    Published 2019
    “…</p><p>Methods</p><p>Peripapillary/macular RVD (using swept-source OCTA), intraocular pressure (IOP), and systemic blood pressure (BP) were measured five times a day (8 a.m., 11 a.m., 2 p.m.,5 p.m. and 8 p.m.). …”
  14. 10394

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…Upon additional modifications of corallorazine D, a candidate compound <b>5k</b>, demonstrated remarkable inhibitory potency against HDAC8 (IC<sub>50</sub> = 0.12 ± 0.01 nM), 89-fold superior to PCI-34051. …”
  15. 10395

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…Upon additional modifications of corallorazine D, a candidate compound <b>5k</b>, demonstrated remarkable inhibitory potency against HDAC8 (IC<sub>50</sub> = 0.12 ± 0.01 nM), 89-fold superior to PCI-34051. …”
  16. 10396

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…Upon additional modifications of corallorazine D, a candidate compound <b>5k</b>, demonstrated remarkable inhibitory potency against HDAC8 (IC<sub>50</sub> = 0.12 ± 0.01 nM), 89-fold superior to PCI-34051. …”
  17. 10397

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…Upon additional modifications of corallorazine D, a candidate compound <b>5k</b>, demonstrated remarkable inhibitory potency against HDAC8 (IC<sub>50</sub> = 0.12 ± 0.01 nM), 89-fold superior to PCI-34051. …”
  18. 10398

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…Upon additional modifications of corallorazine D, a candidate compound <b>5k</b>, demonstrated remarkable inhibitory potency against HDAC8 (IC<sub>50</sub> = 0.12 ± 0.01 nM), 89-fold superior to PCI-34051. …”
  19. 10399

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…Upon additional modifications of corallorazine D, a candidate compound <b>5k</b>, demonstrated remarkable inhibitory potency against HDAC8 (IC<sub>50</sub> = 0.12 ± 0.01 nM), 89-fold superior to PCI-34051. …”
  20. 10400

    Natural Derivatives of Selective HDAC8 Inhibitors with Potent <i>in Vivo</i> Antitumor Efficacy against Breast Cancer by Xiaoming Chen (230202)

    Published 2024
    “…Upon additional modifications of corallorazine D, a candidate compound <b>5k</b>, demonstrated remarkable inhibitory potency against HDAC8 (IC<sub>50</sub> = 0.12 ± 0.01 nM), 89-fold superior to PCI-34051. …”